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Isolation of Human Adult Stem Cells from Muscle 
Biopsy for Future Treatment of Urinary Incontinence
Farzaneh Sharifiaghdas,1 Maryam Taheri,1 Reza Moghadasali2
Purpose: To find a suitable and cost-effective technique for isolation and 
culture of muscle-derived stem cells (MDSCs) obtained from muscle biopsy 
in large quantities.
Materials and Methods: A small muscle biopsy was taken from 10 donor 
rectus muscles in patients undergoing open abdominal surgery for any 
reason and transported on ice to the laboratory. The isolation of MDSCs 
was performed by two techniques; preplate and tissue explants. Initially, 
the isolation was carried out by preplating technique. However, enzymatic 
digestion of muscle biopsy in preplate technique compromised the integrity 
of important surface antigens of resident muscle stem cells and led to 
dysfunctional sorted cells. Also, many of the cells were lost in this technique 
and low numbers of MDSCs were yielded upon processing. Thus, we changed 
condition of centrifuge, but it did not affect cell numbers and their integrities. 
To overcome these problems, the technique was changed to tissue explants 
technique.
Results: During the first 4 days in explant medium culture, activated satellite 
cells detached, migrated, and slowly divided. The MDSCs proliferated 
around the native myofiber and after 2 to 3 weeks, individual muscle cells 
appeared elongated and fused to create large multinucleated myotubes. On 
immunofluorescent staining, these emerged cells were positive for desmin 
and Pax7 and flow cytometry analysis revealed that these cells were CD45-, 
CD56+, and variable in CD34.
Conclusion: We concluded that tissue explant method is a suitable and cost-
effective technique for isolation and culture of MDSCs from muscle biopsy 
in large quantities.
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INTRODUCTION
There are over 200 million people 
throughout the world who suffer 
from incontinence, a condition that 
is associated with social impact and 
a reduced quality of life.(1) Stress 
urinary incontinence (SUI) has 
been reported as the most common 
type of urinary incontinence, and 
cellular therapy with stem cells is a 
new approach to the treatment of 
SUI.(2)
According to previous studies, 
isolation of muscle-derived stem 
cells (MDSCs) from muscle 
biopsy can be done through two 
techniques; preplate and tissue 
explant. However, enzymatic 
digestion of the muscle biopsy in 
preplate technique can compromise 
the integrity of important 
surface antigens of resident 
muscle stem cells, resulting in 
dysfunctional sorted cells, which 
makes the method difficult to be 
reproduced.(2) Also, many of the 
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cells are lost in this technique and low numbers of 
MDSCs are yielded upon processing. Whereas the 
primary tissue explant technique could facilitate 
the proliferation of MDSCs from muscle biopsies 
in vitro. We demonstrated that desmin-positive 
CD45- CD56+ Pax7+ cells isolated by this 
method keep their self-renewal capacity and could 
then be either passaged or differentiated, resulting 
in the fusion of most of the mononucleated cells 
to produce large multinucleated myotubes.
MATERIALS AND METHODS
Stem Cell Sources
Cell Isolation: preplate and tissue explant 
techniques
The isolation of MDSCs was performed using 
previously described preplating technique.(3,4)
A small muscle biopsy (0.5 × 0.5 cm2) was 
taken from 10 donor rectus muscles in patients 
undergoing abdominal surgery for any reason 
and was collected in phosphate buffer saline 
medium (PBS; Gibco, Cat No.21600-051) with 
penicillin 0.05 μ/mL and streptomycin 0.05 μg/
mL transported on ice. In laboratory, the muscle 
biopsy was taken out of the transport media and 
placed in a sterile petri dish. Then, it was minced 
and chopped with razor blades. The minced 
skeletal biopsy was subjected to a triple digest 
strategy. First, it was placed in a collagenase IV, 
solution 0.2% (Gibco, Cat No.17104-019) for 1 
hour at 37°C, with agitation every 10 minutes. 
The solution was centrifuged at 300 × g for 8 
minutes, and the supernatant was discarded. 
Thereafter, the muscle biopsy pellet was 
resuspended in dispase 0.3% (Gibco, Cat No.17105-
041) for 45 minutes at 37°C with agitation every 
10 minutes. The solution was centrifuged at 
300 × g for 8 minutes and the supernatant was 
discarded. Finally, it was resuspended in trypsin–
ethylenediaminetetraacetic acid (EDTA) 0.1% 
(Gibco, Cat No.25300) for 30 minutes at 37°C, 
with agitation every 10 minutes. The solution 
was centrifuged at 300 × g for 8 minutes, and 
the supernatant was discarded. Then, the cell 
suspension was added to a collagen-coated flask 
(Nalgene, Cat No.5409) in Dulbecco’s modified 
Eagles medium (DMEM; Gibco, Cat No.12800-
116), containing 10% fetal bovine serum (FBS; 
Gibco, Cat No. 10270-106), 10% horse serum, 1% 
penicillin-streptomycin (Gibco, Cat No. 15070), 
2mM L-glutamine (L- glu) (Gibco, Cat No. 25030), 
and 0.5% chick embryo extract: Gibco-BRL). After 
1 hour, non adherent cells in suspension were 
removed and transferred to a second flask for a 
period of 2 hours. Fresh medium was added to the 
first set of adherent cells (preplate1, pp1) and this 
procedure was continued for PP3 through PP6 at 
subsequent 24-hour intervals.
According to previous researches performed by 
this technique, six cultures of adherent cells were 
produced with different adhesion characteristics. 
Since in this study triple digest strategy led to 
dysfunctional sorted cells and the number of 
cells was very low, we changed condition of 
centrifuge to 1500 × g for 5 minutes, but it did 
not affect cell numbers and properties. To resolve 
these problems, the technique of isolation of 
MDSCs was changed from preplate to tissue 
explant technique.(5,6) In this technique, the 
minced muscle biopsies were cultured as explant 
in explant medium (M199, Gibco, Cat No.31150) 
and FBS 10% at 37°C, and 5% CO2.
Flow Cytometry
Flow cytometry was used at 2 to 3 weeks and 
6 to 7 weeks to analyze the MDSCs population 
for the expression of surface proteins; CD45, 
CD34, and CD56. Cells were washed in PBS 
+ FBS medium (Dulbecco’s phosphate buffer 
saline; Gibco, Cat No.21600-051, containing 0.5% 
fetal bovine serum; Gibco, Cat No. 10270-106) 
and were fixed by paraformaldehyde 2% (Sigma, 
Cat No. 58H0914). Cells were again washed 
and permeated by Triton X-100 (Sigma, Cat 
No. T8787). Thereafter, the cells were washed 
and divided into four equal aliquots; three for 
combination of various monoclonal antibodies 
and one for control labeling as isotope IgG. 
Predetermined optimal amount of monoclonal 
antibodies (CD45, CD34, and CD56) (Miltenyi 
Biotec, CD45, Cat No.130-080-202, CD34, Cat 
No.130-081-001, and CD56, Cat No.130-090-755) 
were added directly to each tube for 30 minutes. 
These primary antibodies were conjugated with 
fluorescence isothiocyanate and phycoerythrin.
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Finally, the cells were washed and fixed with PBS 
+ FB+ paraformaldehyde. Then, the cells were 
subjected to flow cytometry using BD FACS 
calibur flow cytometer and CellQuest Pro software.
Immunocytochemistry
To assess the expression of proteins in 
relation to myogenic differentiation status, 
immunofluorescent analysis was performed for 
Pax7 and desmin. Cells were washed with PBS 
solution and fixed with paraformaldehyde 4%. 
Then, cells were washed with PBS + Tween 20 
(Sigma, Cat No.P9416) solution twice, permeated 
with Triton X-100 solution, and washed again 
with PBS + Tween 20 solution twice. The cells 
were incubated at room temperature for 1 hour 
with primary antibody anti-desmin (Santa Cruz 
Biotechnology, Cat No.sc-14026) and anti-Pax 
7 (abcam, Cat No.ab34360). After being rinsed 
with PBS + Tween 20 solutions, cells were 
incubated with secondary antibody (fluorescence 
isothiocyanate) (Sigma, Cat No. F1262) for 1 hour 
at room temperature. For visualizing, nuclei cells 
were washed and analyzed on an Olympus CKX 
41 fluorescent microscope and Olympus DP71 
camera.
RESULTS
Cell Growth
During the first 4 days in explant medium culture, 
activated satellite cells detached, migrated, and 
divided slowly. We observed that MDSCs had 
proliferated around the native myofiber and after 
2 to 3 weeks, individual muscle cells appeared 
elongated and fused to create large multinucleated 
myotubes (Figure 1).
Flow Cytometry and Immunocytochemistry
We examined the population of MDSCs isolated 
by explant technique twice; at 2 to 3 weeks and 
6 to 7 weeks. This flow cytometry technique 
was used to analyze the MDSCs population for 
the expression of surface proteins; CD45, CD34, 
and CD56. The total percentage of MDSCs at 
2 to 3 weeks and 6 to 7 weeks were 4.21% and 
5.91% for expressing CD45, 16.21% and 12.55% 
for expressing CD34, and 58.57% and 48.29% 
for expressing CD56, respectively. These results 
are demonstrated in Figure 2 by histograms. 
Immunochemical staining revealed that MDSCs 
were positive for desmin and Pax7 (Figure 3).
Figure 2. Mean percentage of MDSCs populations expressing 
cell surface proteins CD45, CD34, and CD56.
Figure 1. a) During the first 4 days in explant medium culture, activated satellite cells detached and migrated from muscle biopsy b) At 2 
to 3 weeks, individual muscle cells appeared elongated and fused to create large multinucleated myotubes.
a b
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DISCUSSION
Multipotent stem cells have the ability to 
proliferate and differentiate into different cell 
lines. Tissue engineering is a new science to 
regenerate tissues based on the use of stem cells.(7)
The two general types of stem cells that are 
potentially useful for the treatment are embryonic 
stem cells and adult stem cells. The practical use 
of embryonic stem cells is restricted because 
of potential regulatory problems and ethical 
considerations. However, there are no significant 
ethical issues that are related to the use of adult 
stem cells.(1)
Satellite cells are a subpopulation of skeletal 
muscle-derived cells that are capable of self 
renewal and regenerating the muscle after injury, 
the same as the stem cells. Satellite cells, described 
in the classical work of Mauro,(8)are situated 
on the surface of the myofiber between the 
Figure 4. Working model demonstrates quiescent satellite cells 
which are heterogeneous for Pax7 protein.
Figure 3. (a and b) Immunofluorescent staining for detection of Pax7, and (c and d) desmin in MDSCs derived from muscle biopsy by 
tissue culture explant technique.
a
c
b
d
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myofiber plasmalemma and its covering basement 
membrane.
Various cell surface makers have been identified 
to purify adult stem cell population from 
skeletal muscle, including c-kit, sca-l, and CD34. 
Although nearly all muscle-derived hematopoietic 
progenitor cells are derived from CD45+ cells, 
common molecular phenotypes of MDSCs are 
sca-l+, CD45-, and various amounts of CD34.(9)
It appears that the difference with other markers 
might be due to culture conditions associated with 
different techniques or culturing protocols of 
different laboratories.(7)
In the present study, sca-l was not evaluated since 
the human antibody of sca-l was not available. 
Mean expression of CD45 and CD34 at 2 to 3 
weeks and 5 to 6 weeks were 5.06% and 14.38%, 
respectively. We observed that CD45 is not a 
marker of MDSCs and 95% of our cells were 
CD45-. Peault and colleagues(10)and Kayhanian 
and associates(11) proposed CD56 as another 
marker for myogenic cells, which had the mean 
expression of 53.53% in our study.
Deasy and coworkers suggested that Pax7 could 
be considered as a marker of the muscle satellite 
cell, since it is necessary and sufficient for 
specifying of myogenic cells.(7) However, a recent 
study using human biopsies aimed at identifying 
satellite cells in vivo and revealed cells within 
the satellite cell position, but failed to express 
Pax7.(12) Some researchers think that various Pax7 
expressions may also result from the proliferative 
or cycling status of satellite cells.(7)
By working model that is indicated in Figure 4, 
Olguin and Olwin described that satellite cells 
are heterogeneous for Pax7 protein in quiescent 
state.(13) Activation of satellite cells induces up 
regulation of MyoD. Proliferating myoblasts are 
heterogeneous and positive for both MyoD and 
Pax7. A small number of cells differentiate early, 
and induce myogenin and lose Pax7 expression. 
Another small group of cells can act as myoblast 
precursors. It is assumed that co-expression of 
both MyoD and Pax7 is necessary for myoblasts 
to prevent premature differentiation and keep 
them in a proliferative state. For the cells 
committed to differentiation, the myosine 
program goes forward, Pax7 is down regulated 
and MyoD family transcription factors are up 
regulated. A small number of precursor cells will 
go opposite, up regulate Pax7 and down regulate 
MyoD, and form a new satellite pool.
Rouger and colleagues used M-cadherin, Pax7, 
and desmin expression to determine the rate of 
respective progression of cells toward end stage 
myogenic differentiation.(14) In this study, our 
cells were highly positive for immunostaining of 
Pax7and desmin.
CONCLUSION
We found that explant tissue culture is a 
suitable technique for isolation of MDSCs in 
large quantities and this method precludes the 
possible enzymatic destruction of functional 
stem cell markers on cell surface. Also, we 
demonstrated that MDSCs with desmin positive 
markers (CD45-, CD34+/-, CD56+, and Pax7+) 
have self-renewal properties and could then 
differentiate to myoblast, resulting in fusion of 
most of the mononucleated cells to produce large 
multinucleated myotubes in vitro. However, 
further studies are needed to demonstrate the 
applicability of these myotubes as external 
sphincter.
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